1FV

N-{3-[(5-cyclopropyl-2-{[3-(morpholin-4-ylmethyl)phenyl]amino}pyrimidin-4-yl)amino]propyl}cyclobutanecarboxamide

Created:	2013-01-18
Last modified:	2020-06-05

Find Related PDB Entry
4 entries where 1FV is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	70
Chiral Atom Count	0
Bond Count	74
Aromatic Bond Count	12

2D diagram of 1FV

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	N-{3-[(5-cyclopropyl-2-{[3-(morpholin-4-ylmethyl)phenyl]amino}pyrimidin-4-yl)amino]propyl}cyclobutanecarboxamide
Synonyms	MRT67307
Systematic Name (OpenEye OEToolkits)	N-[3-[[5-cyclopropyl-2-[[3-(morpholin-4-ylmethyl)phenyl]amino]pyrimidin-4-yl]amino]propyl]cyclobutanecarboxamide
Formula	C₂₆ H₃₆ N₆ O₂
Molecular Weight	464.603
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=C(NCCCNc1nc(ncc1C2CC2)Nc3cc(ccc3)CN4CCOCC4)C5CCC5
SMILES	CACTVS	3.370	O=C(NCCCNc1nc(Nc2cccc(CN3CCOCC3)c2)ncc1C4CC4)C5CCC5
SMILES	OpenEye OEToolkits	1.7.6	c1cc(cc(c1)Nc2ncc(c(n2)NCCCNC(=O)C3CCC3)C4CC4)CN5CCOCC5
Canonical SMILES	CACTVS	3.370	O=C(NCCCNc1nc(Nc2cccc(CN3CCOCC3)c2)ncc1C4CC4)C5CCC5
Canonical SMILES	OpenEye OEToolkits	1.7.6	c1cc(cc(c1)Nc2ncc(c(n2)NCCCNC(=O)C3CCC3)C4CC4)CN5CCOCC5
InChI	InChI	1.03	InChI=1S/C26H36N6O2/c33-25(21-5-2-6-21)28-11-3-10-27-24-23(20-8-9-20)17-29-26(31-24)30-22-7-1-4-19(16-22)18-32-12-14-34-15-13-32/h1,4,7,16-17,20-21H,2-3,5-6,8-15,18H2,(H,28,33)(H2,27,29,30,31)
InChIKey	InChI	1.03	UKBGBACORPRCGG-UHFFFAOYSA-N

Related Resource References

Resource Name	Reference
Pharos	CHEMBL3605057
PubChem	44464263
ChEMBL	CHEMBL3605057
ChEBI	CHEBI:124930

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.